{
    "body": "Which hormone deficiency is implicated in the Costello syndrome ?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/15940703", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15316968", 
        "http://www.ncbi.nlm.nih.gov/pubmed/17551924", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22752028", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22887473", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16278907", 
        "http://www.ncbi.nlm.nih.gov/pubmed/14564166", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15316966", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20307337", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19035362", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18483625", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21438134", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22821884", 
        "http://www.ncbi.nlm.nih.gov/pubmed/8168845", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19258709"
    ], 
    "ideal_answer": [
        "Growth hormone deficiency is implicated in Costello syndrome. Growth hormone therapy should be administered with caution due to possible severe side effects. Cortisol and sex hormone deficiencies were also implicated in Costello syndrome."
    ], 
    "exact_answer": [
        "Growth hormone deficiency"
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D056685", 
        "http://www.disease-ontology.org/api/metadata/DOID:0050469", 
        "http://www.nlm.nih.gov/cgi/mesh/2014/MB_cgi?field=uid&exact=Find+Exact+Term&term=D006728"
    ], 
    "type": "factoid", 
    "id": "53130a77e3eabad02100000f", 
    "snippets": [
        {
            "offsetInBeginSection": 1019, 
            "offsetInEndSection": 1120, 
            "text": "Measurements obtained after growth hormone exposure in 15 individuals were excluded in this analysis.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22887473", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 789, 
            "offsetInEndSection": 1001, 
            "text": "Furthermore, we observed that RasGRF1 becomes phosphorylated in ARMS after stimulation by several pro-metastatic factors, such as SDF-1 and HGF/SF, as well as after exposure to growth-promoting Igf-2 and insulin.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22752028", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 141, 
            "text": "Progressively worsening hypertrophic cardiomyopathy in a child with newly diagnosed Costello syndrome while receiving growth hormone therapy.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20307337", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 235, 
            "offsetInEndSection": 458, 
            "text": "This report highlights two important concepts: the association of genetic syndromes with hypertrophic cardiomyopathy and the possibility of worsening severity of hypertrophic cardiomyopathy linked to growth hormone therapy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20307337", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 145, 
            "text": "Oncogenic HRAS mutations cause prolonged PI3K signaling in response to epidermal growth factor in fibroblasts of patients with Costello syndrome.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19035362", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 994, 
            "offsetInEndSection": 1291, 
            "text": "Statistical significance was achieved, despite the relatively small number of patients with BRAF and MEK1 mutations reported here, for polyhydramnios, growth hormone deficiency and the presence of more than one papilloma, which were less common in CFC compared to HRAS mutation positive patients. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/17551924", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 236, 
            "offsetInEndSection": 503, 
            "text": "Endocrine abnormalities including growth hormone deficiency, adrenal insufficiency, glucose intolerance, parathyroid adenoma with hyperprolactinemia and hypoglycemia have been described. Hypoglycemia has been documented due to growth hormone and cortisol deficiency. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16278907", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 373, 
            "offsetInEndSection": 468, 
            "text": "Endocrine problems in this series were osteoporosis, central hypogonadism, and delayed puberty.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15940703", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 47, 
            "text": "Growth hormone deficiency in Costello syndrome.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316968", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 458, 
            "text": "We report on three patients with Costello syndrome and isolated growth hormone (GH) deficiency treated with biosynthetic GH. To our knowledge, these are the only patients with Costello syndrome who have been successfully treated for GH deficiency. We review the pathophysiology of Costello syndrome and highlight the recent recommendations of tumor screening and cardiac surveillance in this population, of particular relevance to those receiving GH therapy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316968", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 121, 
            "text": "Costello syndrome with growth hormone deficiency and hypoglycemia: a new report and review of the endocrine associations.", 
            "beginSection": "title", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316966", 
            "endSection": "title"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 281, 
            "text": "We describe an 18-month-old boy with Costello syndrome (CS) with proven partial growth hormone (GH) deficiency and hypoglycemic episodes. The hypoglycemia is deemed to be due to cortisol deficiency. This report represents the second published case of cortisol deficiency in the CS.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15316966", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 130, 
            "text": "We present the case of a boy with Costello syndrome who developed osteofibrous dysplasia during a phase of growth hormone therapy.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14564166", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 338, 
            "offsetInEndSection": 520, 
            "text": "Thus, although osteofibrous dysplasia in Costello syndrome has not been reported before, growth hormone therapy should be used under close supervision in children with this syndrome.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/14564166", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 332, 
            "offsetInEndSection": 412, 
            "text": "Endocrinological investigations revealed a partial deficiency of growth hormone.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/8168845", 
            "endSection": "abstract"
        }
    ]
}